Skip to main content
. 2020 Oct 29;46(1):E74–E87. doi: 10.1503/jpn.200032

Table 2.

Summary statistics and group differences for demographic and clinical measures

Sample Healthy controls Depression/anxiety Substance use disorders p value
Full sample n = 59 n = 260 n = 159
 Age, yr 32.14 ± 11.13 35.89 ± 11.30 33.93 ± 9.09 0.024
 Male, n (%) 28 (48) 70 (27) 74 (47) < 0.001
 PHQ score 0.90 ± 1.36 12.63 ± 5.14 6.50 ± 5.66 < 0.001
 OASIS score 1.27 ± 1.88 9.80 ± 3.42 5.78 ± 4.66 < 0.001
 DAST-10 score 0.12 ± 0.38 0.67 ± 1.41 7.48 ± 2.20 < 0.001
 WRAT score 62.37 ± 5.06 63.53 ± 4.76 58.49 ± 5.65 < 0.001
Propensity-matched sample n = 59 n = 161 n = 56
 Age, yr 32.14 ± 11.13 35.11 ± 10.84 32.67 ± 10.26 0.12
 Male, n (%) 28 (48) 41 (25) 35 (63) < 0.001
 PHQ score 0.90 ± 1.36 12.64 ± 5.38 7.95 ± 6.50 < 0.001
 OASIS score 1.27 ± 1.88 9.78 ± 3.42 6.80 ± 5.15 < 0.001
 DAST-10 score 0.12 ± 0.38 0.62 ± 1.26 7.45 ± 2.65 < 0.001
 WRAT score 63.53 ± 4.76 62.58 ± 4.53 61.89 ± 4.43 0.15

DAST-10 = Drug Abuse Screening Test; OASIS = Overall Anxiety Severity and Impairment Scale; PHQ = Patient Health Questionnaire; WRAT = Wide Range Achievement Test.

Unless otherwise indicated, findings are mean ± standard deviation.